ADVANCED BILIARY TRACT CARCINOMA
Clinical trials for ADVANCED BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for tough liver and bile duct cancers
Disease control CompletedThis study tested a new combination treatment for people with advanced liver cancer or bile duct cancer. The treatment combines an immunotherapy drug (SHR-1210) with either a targeted therapy (apatinib) or chemotherapy. The goal was to see if the combination is safe and can shrin…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New hope for bile duct cancer? keytruda and lenvima combo tested
Disease control CompletedThis phase 2 trial tested a combination of two drugs, pembrolizumab (Keytruda) and lenvatinib (Lenvima), in 27 people with advanced biliary tract cancer that had worsened after standard treatment. The goal was to see if the combination could shrink tumors. The study is now comple…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Jiahui International Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC